As of January 22, 2025, Clearside Biomedical (CLSD) has a market cap of $73.947 million USD. According to our data, Clearside Biomedical is ranked No.7924 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $73.95 M |
2.63%
|
Dec 31, 2024 | $72.05 M |
-18.80%
|
Dec 29, 2023 | $88.74 M |
4.46%
|
Dec 30, 2022 | $84.94 M |
-59.27%
|
Dec 31, 2021 | $0.21 B |
0.36%
|
Dec 31, 2020 | $0.21 B |
-5.52%
|
Dec 31, 2019 | $0.22 B |
171.03%
|
Dec 31, 2018 | $81.15 M |
-84.71%
|
Dec 29, 2017 | $0.53 B |
-21.70%
|
Dec 30, 2016 | $0.68 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Alimera Sciences
ALIM
|
$0.30 B |
0.000 M
|
USA
|
EyePoint Pharmaceuticals
EYPT
|
$0.58 B |
-0.000 M
|
USA
|
Bausch Health
BHC
|
$2.85 B |
6.423 M
|
Canada
|
Novartis
NVS
|
$196.25 B |
0.003 M
|
Switzerland
|
Pfizer
PFE
|
$147.43 B |
0.004 M
|
USA
|
Kala Pharmaceuticals
KALA
|
$36.48 M |
-0.000 M
|
USA
|
Adverum Biotechnologies
ADVM
|
$93.20 M |
0.000 M
|
USA
|
Ocular Therapeutix
OCUL
|
$1.26 B |
-0.000 M
|
USA
|
Kodiak Sciences
KOD
|
$0.42 B |
-0.000 M
|
USA
|
Ginkgo Bioworks
DNA
|
$0.74 B |
0.157 B
|
USA
|
Market Cap | = | CLSD Stock Price | * | CLSD Shares Outstanding |
= | $0.98 | * | 75.84 M | |
= | $73.95 M |